SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

How Musk’s X account floods feeds with pro-Trump messages and election misinformation

Harris vs. Trump: Competing visions for America's economic future

Is ChatGPT about to upend Google’s long-reigning search dominance?

Intel aims to net billions in Altera stake sale, targeting $17 billion valuation

Buzz

Most popular

Daily

Weekly

1

Wiz eyeing Dazz acquisition in deal worth hundreds of millions

2

Four years and billions later, Intel’s Habana Labs is still searching for success amid layoffs

3

Intel's workforce questions its future amid layoffs and shrinking benefits

4

From Intel to Meta: How high-tech giants are rethinking employee perks

5

Sequoia-backed Decart raises $21M in Seed funding to pioneer scalable, cost-efficient GenAI

NeuroSense

2 stories about NeuroSense

NeuroSense & NeuraLight R&D Teams

NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI

The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it

תרופה תרופות סל התרופות

ALS Drug Developer NeuroSense Crowdfunds $1.15 Million

05.08.19|Adi Pick

The company’s 1,114 new investors will jointly own a 10% stake, the company said